Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease

Despite the growing number of new drugs approved for the treatment of inflammatory bowel disease (IBD), the long-term clinical use of thiopurine therapy and the well-known properties of conventional drugs including azathioprine have made their place in IBD therapy extremely valuable. Despite the fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazarević, Slavica, Đanic, Maja, Al-Salami, Hani, Mooranian, Armin, Mikov, Momir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016117/
https://www.ncbi.nlm.nih.gov/pubmed/35450035
http://dx.doi.org/10.3389/fphar.2022.879170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016117/
https://www.ncbi.nlm.nih.gov/pubmed/35450035
http://dx.doi.org/10.3389/fphar.2022.879170

Ejemplares similares